Founded in by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

A new report says that drugmakers could lose billions of dollars per year if marijuana is legaliz Allergan executives hint at what's in store for the drugmaker at the Goldman Sachs healthcare con Billionaires appear to have focused on drug stocks that were mired in debt in Q1. If President Trump cracks down on drug price inflation, these pharma and biotech offenders could Allergan, Express Scripts, and Vertex stocks look attractive in a generally overpriced market.

Gilead Sciences might want to pay attention to Allergan's aggressive expansion of its NASH program.

These three stocks have attracted some of brightest investors in the world. Shares respond positively to the announcement of upbeat data from a phase 3 study. Billionaire investors are pouring more money into healthcare stocks -- especially Allergan, Johns It's time for biopharma to double down on growing sales and profits through research and developm With his company's stock down big over the last year, Allergan CEO Brent Saunders faced tough que President-elect Donald Trump took aim at drug developers in a recent Time magazine interview and Billionaire money managers wanted little to do with these big names during the third quarter.

These drugmakers found themselves on the hedge-fund chopping block in the third quarter. These three pharma stocks' investors jumped for joy at the prospect of a Trump presidency. The drugmaker's stock took a dip in October over the raging drug pricing debate.

AGN:New York Stock Quote - Allergan PLC - Bloomberg Markets

A Hillary Clinton win should help reverse the fortunes of Allergan and Horizon Pharma. There was slow revenue growth and disappointing earnings for Allergan in Q3, but better things co Our Foolish contributors think these seven top stocks are worth checking out this month.

Shares more than double in response to the company accepting a buyout offer. A dividend would make this stock appealing to long-term investors, and with its newfound cash bou It can be difficult to hold on to stocks for decades at a time, because investors can't predict t Billionaire investors Warren Buffett, George Soros, and Carl Icahn recently made these big bets. Allergan is back on the hunt for deals -- but not the ones you might expect.

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Have feedback on The Motley Fool site?

We'd love to hear from you.

AGN - Allergan Stock quote - yzyjifoh.web.fc2.com

BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes. Real-Time prices provided by BATS BZX. Market data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.

Allergan plc Ordinary Shares: NYSE:AGN quotes & news - Google Finance

SEC Filings and Insider Transactions provided by Edgar Online. Powered and implemented by Interactive Data Managed Solutions. Skip to main content The Motley Fool Fool.

Premium Advice Help Fool Answers Contact Us Login. Latest Stock Picks Stocks Premium Services. Stock Advisor Flagship service. Rule Breakers High-growth stocks. Income Investor Dividend stocks.

Hidden Gems Small-cap stocks. Inside Value Undervalued stocks. Learn How to Invest. Credit Cards Best Credit Cards of Best Credit Card Sign-Up Bonuses Best Balance-Transfer Credit Cards Best Travel Credit Cards Best Cash-Back Credit Cards Best No-Annual-Fee Credit Cards Best Small Business Credit Cards. Mortgages Compare Mortgage Rates Get Pre-Approved How Much House Can I Afford?

Taxes How to Reduce Your Taxes Deductions Even Pros Overlook Audit-Proof Your Tax Return What Info Should I Keep? Helping the World Invest — Better. How to Invest Learn How to Invest. Personal Finance Credit Cards Best Credit Cards of Best Credit Card Sign-Up Bonuses Best Balance-Transfer Credit Cards Best Travel Credit Cards Best Cash-Back Credit Cards Best No-Annual-Fee Credit Cards Best Small Business Credit Cards.

Updates from The Motley Fool Latest updates on Allergan from Fool. The Fool has written over articles on Allergan.

Could Legalized Marijuana Be Making Big Pharma Nervous? Should Gilead Sciences Be Worried About Allergan?

AGN Stock Price & News - Allergan PLC - Wall Street Journal

Why Paratek Pharmaceuticals Inc Is Soaring Shares respond positively to the announcement of upbeat data from a phase 3 study. Billionaires Love These 3 Healthcare Stocks Billionaire investors are pouring more money into healthcare stocks -- especially Allergan, Johns More Innovation, Better Execution, and Fewer Price Hikes It's time for biopharma to double down on growing sales and profits through research and developm Allergan CEO on the Hot Seat: Here's What He Had to Say With his company's stock down big over the last year, Allergan CEO Brent Saunders faced tough que Trump Warns Investors "I'm Going To Bring Down Drug Prices" President-elect Donald Trump took aim at drug developers in a recent Time magazine interview and Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday These three pharma stocks' investors jumped for joy at the prospect of a Trump presidency.

If Hillary Clinton Wins, These 2 Beaten-Down Stocks Are Buys A Hillary Clinton win should help reverse the fortunes of Allergan and Horizon Pharma. Here's Why Shares of Vitae Pharmaceuticals Inc Are Skyrocketing Today Shares more than double in response to the company accepting a buyout offer.

Why Allergan Should Start Paying a Dividend A dividend would make this stock appealing to long-term investors, and with its newfound cash bou Allergan Makes an Eye-Opening Acquisition Allergan is back on the hunt for deals -- but not the ones you might expect. Key Data Points Primary metrics and data points about Allergan. Company Rating What our community thinks about Allergan. How do you think Allergan will perform against the market?

CEO Rating The single most important factor in a company's success is the team that's leading the company. Business Summary Industry, sector and description for Allergan.